Sarepta Therapeutics Inc (NASDAQ:SRPT)
A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions